-
UCB Announces U.S. FDA Approval for Zilbrysq (zilucoplan) Autoinjector Self-administration for Adults Living with Generalized Myasthenia Gravis
Brussels, Belgium and Atlanta, Georgia – October 16, 2026 – UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first self-administered… Source: Read More
-
New Treatment Option: FDA Approves Autoinjector for Leqvio (inclisiran)
A Milestone for Cholesterol Management The U.S. Food and Drug Administration (FDA) has officially approved a new autoinjector version of Leqvio (inclisiran). This update marks an important step forward for patients who require ongoing management of high cholesterol and are looking for more convenient ways to administer their prescribed treatment. Understanding the Update Leqvio is…